Selected research
Market Structure
Global Home Pet Deworming Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Home Pet Deworming Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Home Pet Deworming Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Home Pet Deworming Medicine include Zoetis, Merck & Co, Inc., Sava Healthcare Limited, Boehringer Ingelheim International GmbH, Ceva, Elanco, Virbac, PetIQ, LLC and Liquid Fence, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Home Pet Deworming Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Home Pet Deworming Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Home Pet Deworming Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Home Pet Deworming Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Home Pet Deworming Medicine Segment by Company
Zoetis
Merck & Co, Inc.
Sava Healthcare Limited
Boehringer Ingelheim International GmbH
Ceva
Elanco
Virbac
PetIQ, LLC
Liquid Fence
Bird-X
HortiCentre
Green Gardener
The Big Cheese
Yorkshire Trading Company
Ramical
Beaphar
Agland
Home Pet Deworming Medicine Segment by Type
Internal Deworming
External Deworming
Home Pet Deworming Medicine Segment by Application
Cats
Dogs
Others
Home Pet Deworming Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Pet Deworming Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home Pet Deworming Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Pet Deworming Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Home Pet Deworming Medicine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Home Pet Deworming Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Home Pet Deworming Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Home Pet Deworming Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Internal Deworming
- External Deworming
Applications
- Cats
- Dogs
- Others
Companies covered
- Zoetis
- Merck & Co, Inc.
- Sava Healthcare Limited
- Boehringer Ingelheim International GmbH
- Ceva
- Elanco
- Virbac
- PetIQ, LLC
- Liquid Fence
- Bird-X
- HortiCentre
- Green Gardener
- The Big Cheese
- Yorkshire Trading Company
- Ramical
- Beaphar
- Agland
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Home Pet Deworming Medicine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Home Pet Deworming Medicine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Home Pet Deworming Medicine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Home Pet Deworming Medicine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Home Pet Deworming Medicine Market Dynamics
- 2.1 Home Pet Deworming Medicine Industry Trends
- 2.2 Home Pet Deworming Medicine Industry Drivers
- 2.3 Home Pet Deworming Medicine Industry Opportunities and Challenges
- 2.4 Home Pet Deworming Medicine Industry Restraints
3 Home Pet Deworming Medicine Market by Manufacturers
- 3.1 Global Home Pet Deworming Medicine Revenue by Manufacturers (2021-2026)
- 3.2 Global Home Pet Deworming Medicine Sales by Manufacturers (2021-2026)
- 3.3 Global Home Pet Deworming Medicine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Home Pet Deworming Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Home Pet Deworming Medicine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Home Pet Deworming Medicine Manufacturers, Product Type & Application
- 3.7 Global Home Pet Deworming Medicine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Home Pet Deworming Medicine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Home Pet Deworming Medicine Players Market Share by Revenue in 2025
- 3.8.3 2025 Home Pet Deworming Medicine Tier 1, Tier 2, and Tier 3
4 Home Pet Deworming Medicine Market by Type
- 4.1 Home Pet Deworming Medicine Type Introduction
- 4.1.1 Internal Deworming
- 4.1.2 External Deworming
- 4.2 Global Home Pet Deworming Medicine Sales by Type
- 4.2.1 Global Home Pet Deworming Medicine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Home Pet Deworming Medicine Sales by Type (2021-2032)
- 4.2.3 Global Home Pet Deworming Medicine Sales Market Share by Type (2021-2032)
- 4.3 Global Home Pet Deworming Medicine Revenue by Type
- 4.3.1 Global Home Pet Deworming Medicine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Home Pet Deworming Medicine Revenue by Type (2021-2032)
- 4.3.3 Global Home Pet Deworming Medicine Revenue Market Share by Type (2021-2032)
5 Home Pet Deworming Medicine Market by Application
- 5.1 Home Pet Deworming Medicine Application Introduction
- 5.1.1 Cats
- 5.1.2 Dogs
- 5.1.3 Others
- 5.2 Global Home Pet Deworming Medicine Sales by Application
- 5.2.1 Global Home Pet Deworming Medicine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Home Pet Deworming Medicine Sales by Application (2021-2032)
- 5.2.3 Global Home Pet Deworming Medicine Sales Market Share by Application (2021-2032)
- 5.3 Global Home Pet Deworming Medicine Revenue by Application
- 5.3.1 Global Home Pet Deworming Medicine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Home Pet Deworming Medicine Revenue by Application (2021-2032)
- 5.3.3 Global Home Pet Deworming Medicine Revenue Market Share by Application (2021-2032)
6 Global Home Pet Deworming Medicine Sales by Region
- 6.1 Global Home Pet Deworming Medicine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Home Pet Deworming Medicine Sales by Region (2021-2032)
- 6.2.1 Global Home Pet Deworming Medicine Sales by Region (2021-2026)
- 6.2.2 Global Home Pet Deworming Medicine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Home Pet Deworming Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Home Pet Deworming Medicine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Home Pet Deworming Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Home Pet Deworming Medicine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Home Pet Deworming Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Home Pet Deworming Medicine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Home Pet Deworming Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Home Pet Deworming Medicine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Home Pet Deworming Medicine Revenue by Region
- 7.1 Global Home Pet Deworming Medicine Revenue by Region
- 7.1.1 Global Home Pet Deworming Medicine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Home Pet Deworming Medicine Revenue by Region (2021-2026)
- 7.1.3 Global Home Pet Deworming Medicine Revenue by Region (2027-2032)
- 7.1.4 Global Home Pet Deworming Medicine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Home Pet Deworming Medicine Revenue (2021-2032)
- 7.2.2 North America Home Pet Deworming Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Home Pet Deworming Medicine Revenue (2021-2032)
- 7.3.2 Europe Home Pet Deworming Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Home Pet Deworming Medicine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Home Pet Deworming Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Home Pet Deworming Medicine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Home Pet Deworming Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zoetis
- 8.1.1 Zoetis Company Information
- 8.1.2 Zoetis Business Overview
- 8.1.3 Zoetis Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zoetis Home Pet Deworming Medicine Product Portfolio
- 8.1.5 Zoetis Recent Developments
- 8.2 Merck & Co, Inc.
- 8.2.1 Merck & Co, Inc. Company Information
- 8.2.2 Merck & Co, Inc. Business Overview
- 8.2.3 Merck & Co, Inc. Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck & Co, Inc. Home Pet Deworming Medicine Product Portfolio
- 8.2.5 Merck & Co, Inc. Recent Developments
- 8.3 Sava Healthcare Limited
- 8.3.1 Sava Healthcare Limited Company Information
- 8.3.2 Sava Healthcare Limited Business Overview
- 8.3.3 Sava Healthcare Limited Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sava Healthcare Limited Home Pet Deworming Medicine Product Portfolio
- 8.3.5 Sava Healthcare Limited Recent Developments
- 8.4 Boehringer Ingelheim International GmbH
- 8.4.1 Boehringer Ingelheim International GmbH Company Information
- 8.4.2 Boehringer Ingelheim International GmbH Business Overview
- 8.4.3 Boehringer Ingelheim International GmbH Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Boehringer Ingelheim International GmbH Home Pet Deworming Medicine Product Portfolio
- 8.4.5 Boehringer Ingelheim International GmbH Recent Developments
- 8.5 Ceva
- 8.5.1 Ceva Company Information
- 8.5.2 Ceva Business Overview
- 8.5.3 Ceva Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Ceva Home Pet Deworming Medicine Product Portfolio
- 8.5.5 Ceva Recent Developments
- 8.6 Elanco
- 8.6.1 Elanco Company Information
- 8.6.2 Elanco Business Overview
- 8.6.3 Elanco Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Elanco Home Pet Deworming Medicine Product Portfolio
- 8.6.5 Elanco Recent Developments
- 8.7 Virbac
- 8.7.1 Virbac Company Information
- 8.7.2 Virbac Business Overview
- 8.7.3 Virbac Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Virbac Home Pet Deworming Medicine Product Portfolio
- 8.7.5 Virbac Recent Developments
- 8.8 PetIQ, LLC
- 8.8.1 PetIQ, LLC Company Information
- 8.8.2 PetIQ, LLC Business Overview
- 8.8.3 PetIQ, LLC Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 PetIQ, LLC Home Pet Deworming Medicine Product Portfolio
- 8.8.5 PetIQ, LLC Recent Developments
- 8.9 Liquid Fence
- 8.9.1 Liquid Fence Company Information
- 8.9.2 Liquid Fence Business Overview
- 8.9.3 Liquid Fence Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Liquid Fence Home Pet Deworming Medicine Product Portfolio
- 8.9.5 Liquid Fence Recent Developments
- 8.10 Bird-X
- 8.10.1 Bird-X Company Information
- 8.10.2 Bird-X Business Overview
- 8.10.3 Bird-X Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Bird-X Home Pet Deworming Medicine Product Portfolio
- 8.10.5 Bird-X Recent Developments
- 8.11 HortiCentre
- 8.11.1 HortiCentre Company Information
- 8.11.2 HortiCentre Business Overview
- 8.11.3 HortiCentre Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 HortiCentre Home Pet Deworming Medicine Product Portfolio
- 8.11.5 HortiCentre Recent Developments
- 8.12 Green Gardener
- 8.12.1 Green Gardener Company Information
- 8.12.2 Green Gardener Business Overview
- 8.12.3 Green Gardener Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Green Gardener Home Pet Deworming Medicine Product Portfolio
- 8.12.5 Green Gardener Recent Developments
- 8.13 The Big Cheese
- 8.13.1 The Big Cheese Company Information
- 8.13.2 The Big Cheese Business Overview
- 8.13.3 The Big Cheese Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 The Big Cheese Home Pet Deworming Medicine Product Portfolio
- 8.13.5 The Big Cheese Recent Developments
- 8.14 Yorkshire Trading Company
- 8.14.1 Yorkshire Trading Company Company Information
- 8.14.2 Yorkshire Trading Company Business Overview
- 8.14.3 Yorkshire Trading Company Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Yorkshire Trading Company Home Pet Deworming Medicine Product Portfolio
- 8.14.5 Yorkshire Trading Company Recent Developments
- 8.15 Ramical
- 8.15.1 Ramical Company Information
- 8.15.2 Ramical Business Overview
- 8.15.3 Ramical Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Ramical Home Pet Deworming Medicine Product Portfolio
- 8.15.5 Ramical Recent Developments
- 8.16 Beaphar
- 8.16.1 Beaphar Company Information
- 8.16.2 Beaphar Business Overview
- 8.16.3 Beaphar Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Beaphar Home Pet Deworming Medicine Product Portfolio
- 8.16.5 Beaphar Recent Developments
- 8.17 Agland
- 8.17.1 Agland Company Information
- 8.17.2 Agland Business Overview
- 8.17.3 Agland Home Pet Deworming Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Agland Home Pet Deworming Medicine Product Portfolio
- 8.17.5 Agland Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Home Pet Deworming Medicine Value Chain Analysis
- 9.1.1 Home Pet Deworming Medicine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Home Pet Deworming Medicine Production Mode & Process
- 9.2 Home Pet Deworming Medicine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Home Pet Deworming Medicine Distributors
- 9.2.3 Home Pet Deworming Medicine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst